Discovery of Dual GyrB/ParE Inhibitors Active Against Gram-negative Bacteria
Overview
Authors
Affiliations
Even though many GyrB and ParE inhibitors have been reported in the literature, few possess activity against Gram-negative bacteria. This is primarily due to limited permeability across Gram-negative bacterial membrane as well as bacterial efflux mechanisms. Permeability of compounds across Gram-negative bacterial membranes depends on many factors including physicochemical properties of the inhibitors. Herein, we show the optimization of pyridylureas leading to compounds with potent activity against Gram-negative bacterial species such as P.aeruginosa, E.coli and A.baumannii.
Gutierrez L, Persolja P, Tosso R, Zidar N, Kikelj D, Enriz R RSC Med Chem. 2024; .
PMID: 39290385 PMC: 11403825. DOI: 10.1039/d4md00498a.
New -phenylpyrrolamide inhibitors of DNA gyrase with improved antibacterial activity.
Cotman A, Fulgheri F, Piga M, Persolja P, Tiz D, Skok Z RSC Adv. 2024; 14(39):28423-28454.
PMID: 39247510 PMC: 11378028. DOI: 10.1039/d4ra04802d.
Rational design of balanced dual-targeting antibiotics with limited resistance.
Nyerges A, Tomasic T, Durcik M, Revesz T, Szili P, Draskovits G PLoS Biol. 2020; 18(10):e3000819.
PMID: 33017402 PMC: 7561186. DOI: 10.1371/journal.pbio.3000819.